NCT06325345View on ClinicalTrials.gov

RCT of Gut-directed Hypnotherapy in Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders

NANot yet recruitingINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

December 29, 2024

Study Completion Date

April 1, 2025

Conditions
Ehlers-Danlos SyndromeIrritable Bowel SyndromeHypermobility SyndromeGastrointestinal Dysfunction
Interventions
BEHAVIORAL

Gut-directed hypnotherapy

Eight session gut-directed hypnotherapy for IBS symptoms adapted from the evidence-based Manchester protocol for treatment of IBS.

OTHER

Standard Medical Therapy

Standard medical treatment will be administered by board certified gastroenterologists

Trial Locations (1)

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT06325345 - RCT of Gut-directed Hypnotherapy in Ehlers-Danlos Syndromes and Generalized Hypermobility Spectrum Disorders | Biotech Hunter | Biotech Hunter